JP2010502175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502175A5 JP2010502175A5 JP2009526123A JP2009526123A JP2010502175A5 JP 2010502175 A5 JP2010502175 A5 JP 2010502175A5 JP 2009526123 A JP2009526123 A JP 2009526123A JP 2009526123 A JP2009526123 A JP 2009526123A JP 2010502175 A5 JP2010502175 A5 JP 2010502175A5
- Authority
- JP
- Japan
- Prior art keywords
- model
- cells
- monocytes
- cell
- epithelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 42
- 238000000034 method Methods 0.000 claims 33
- 210000001616 monocyte Anatomy 0.000 claims 27
- 210000001821 langerhans cell Anatomy 0.000 claims 20
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 18
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 18
- 238000013334 tissue model Methods 0.000 claims 16
- 210000002950 fibroblast Anatomy 0.000 claims 13
- 210000002510 keratinocyte Anatomy 0.000 claims 13
- 210000002889 endothelial cell Anatomy 0.000 claims 11
- 210000002540 macrophage Anatomy 0.000 claims 11
- 210000003491 skin Anatomy 0.000 claims 11
- 239000012528 membrane Substances 0.000 claims 10
- 210000002919 epithelial cell Anatomy 0.000 claims 9
- 210000004379 membrane Anatomy 0.000 claims 9
- 210000001519 tissue Anatomy 0.000 claims 8
- 210000004207 dermis Anatomy 0.000 claims 7
- 239000011159 matrix material Substances 0.000 claims 7
- 210000004369 blood Anatomy 0.000 claims 6
- 239000008280 blood Substances 0.000 claims 6
- 230000001413 cellular effect Effects 0.000 claims 6
- 230000004069 differentiation Effects 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- 230000002500 effect on skin Effects 0.000 claims 5
- 230000002093 peripheral effect Effects 0.000 claims 5
- 239000002537 cosmetic Substances 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 238000012360 testing method Methods 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 3
- 210000001136 chorion Anatomy 0.000 claims 3
- 210000002615 epidermis Anatomy 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 210000002752 melanocyte Anatomy 0.000 claims 3
- 210000000716 merkel cell Anatomy 0.000 claims 3
- 238000010899 nucleation Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 241001430294 unidentified retrovirus Species 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 238000002659 cell therapy Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000007794 irritation Effects 0.000 claims 2
- 230000007246 mechanism Effects 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000004400 mucous membrane Anatomy 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 229920000515 polycarbonate Polymers 0.000 claims 2
- 239000004417 polycarbonate Substances 0.000 claims 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims 2
- -1 polytetrafluoroethylene Polymers 0.000 claims 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
- 210000004927 skin cell Anatomy 0.000 claims 2
- 210000001626 skin fibroblast Anatomy 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 239000000020 Nitrocellulose Substances 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 206010034972 Photosensitivity reaction Diseases 0.000 claims 1
- 239000004793 Polystyrene Substances 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 229920006362 Teflon® Polymers 0.000 claims 1
- 210000001789 adipocyte Anatomy 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 210000004082 barrier epithelial cell Anatomy 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000013098 chemical test method Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 230000007123 defense Effects 0.000 claims 1
- 210000003595 dermal dendritic cell Anatomy 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 claims 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims 1
- 230000004890 epithelial barrier function Effects 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 230000008102 immune modulation Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000006058 immune tolerance Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 210000003535 interstitial dendritic cell Anatomy 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 229920001220 nitrocellulos Polymers 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000003711 photoprotective effect Effects 0.000 claims 1
- 208000007578 phototoxic dermatitis Diseases 0.000 claims 1
- 231100000018 phototoxicity Toxicity 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 210000001732 sebaceous gland Anatomy 0.000 claims 1
- 230000001235 sensitizing effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 231100000041 toxicology testing Toxicity 0.000 claims 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0653567A FR2905380B1 (fr) | 2006-09-04 | 2006-09-04 | Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+ |
| PCT/EP2007/059165 WO2008028882A1 (en) | 2006-09-04 | 2007-09-03 | A method for producing langerhans cells and/or dermal/interstitial dentritic cells from cd14+ monocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010502175A JP2010502175A (ja) | 2010-01-28 |
| JP2010502175A5 true JP2010502175A5 (cg-RX-API-DMAC7.html) | 2010-10-21 |
Family
ID=37781699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009526123A Pending JP2010502175A (ja) | 2006-09-04 | 2007-09-03 | Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2064318A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010502175A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090049620A (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0716107A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2662231A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2905380B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008028882A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010225438A1 (en) * | 2009-03-17 | 2011-10-13 | The Heart Research Institute Ltd | Method of cell differentiation and uses therefor in screening, diagnosis and therapy |
| GB201700138D0 (en) | 2017-01-05 | 2017-02-22 | Senzagen Ab | Analytical methods and arrays for use in the same |
| US20220025337A1 (en) * | 2018-11-30 | 2022-01-27 | Shiseido Company, Ltd. | Pigmentation skin model and method for producing same, and method for evaluating factor for treating or preventing pigmentation of skin |
| EP3991797A4 (en) * | 2019-09-17 | 2023-06-14 | Toppan Inc. | CELL STRUCTURE AND METHODS OF PRODUCTION THEREOF |
| FR3132146B1 (fr) * | 2022-01-27 | 2025-10-31 | Genoskin | Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2743817B1 (fr) * | 1996-01-23 | 1998-03-13 | Oreal | Equivalent de peau comprenant des cellules de langerhans |
| US7566568B2 (en) * | 2001-04-27 | 2009-07-28 | Istituto Superiore Di Sanita | Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| FR2833271B1 (fr) * | 2001-12-10 | 2004-09-17 | Coletica | Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles |
| WO2005007839A1 (ja) * | 2003-07-22 | 2005-01-27 | Kirin Beer Kabushiki Kaisha | ノッチリガンドDelta-1、GM-CSF、TGF-βを用いたヒト末梢血単核球であるCD14陽性細胞からのランゲルハンス細胞の調製方法 |
-
2006
- 2006-09-04 FR FR0653567A patent/FR2905380B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-03 EP EP07803152A patent/EP2064318A1/en not_active Withdrawn
- 2007-09-03 JP JP2009526123A patent/JP2010502175A/ja active Pending
- 2007-09-03 WO PCT/EP2007/059165 patent/WO2008028882A1/en not_active Ceased
- 2007-09-03 CA CA002662231A patent/CA2662231A1/en not_active Abandoned
- 2007-09-03 KR KR1020097006847A patent/KR20090049620A/ko not_active Ceased
- 2007-09-03 BR BRPI0716107-7A2A patent/BRPI0716107A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Su et al. | Dissolvable Microneedles Coupled with Nanofiber Dressings Eradicate Biofilms via Effectively Delivering a Database Designed Antimicrobial Peptide | |
| Zhou et al. | Multifunctional DNA hydrogels with hydrocolloid‐cotton structure for regeneration of diabetic infectious wounds | |
| Yang et al. | A sponge-like double-layer wound dressing with chitosan and decellularized bovine amniotic membrane for promoting diabetic wound healing | |
| Annabi et al. | Highly elastic micropatterned hydrogel for engineering functional cardiac tissue | |
| Liu et al. | Small extracellular vesicles: Yields, functionalization and applications in diabetic wound management | |
| Silva et al. | Topical caffeine delivery using biocellulose membranes: a potential innovative system for cellulite treatment | |
| Varkey et al. | Advances in skin substitutes—potential of tissue engineered skin for facilitating anti-fibrotic healing | |
| Cadinoiu et al. | Silver nanoparticles biocomposite films with antimicrobial activity: In vitro and in vivo tests | |
| Surowiecka et al. | Mesenchymal stem cells in burn wound management | |
| Ansaf et al. | 3D bioprinting—a model for skin aging | |
| DE10297513C5 (de) | In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten | |
| Shah et al. | Mapping the mechanical and immunological profiles of polymeric microneedles to enable vaccine and immunotherapy applications | |
| Nahm et al. | Exosomes in dermatology: a comprehensive review of current applications, clinical evidence, and future directions | |
| Rahnama et al. | A comprehensive evaluation of dermal fibroblast therapy in clinical trials for treating skin disorders and cosmetic applications: a scoping review | |
| US20260014096A1 (en) | Medical patch for controlled delivery of wound healing factors and therapies | |
| Maestas Jr et al. | Helminth egg derivatives as proregenerative immunotherapies | |
| Li et al. | Euglena gracilis and its aqueous extract constructed with chitosan-hyaluronic acid hydrogel facilitate cutaneous wound healing in mice without inducing excessive inflammatory response | |
| Ramos-Rodriguez et al. | Delivery of bioactive compounds to improve skin cell responses on microfabricated electrospun microenvironments | |
| Cheng et al. | An in vitro and ex vivo wound infection model to test topical and systemic treatment with antibiotics | |
| Galili et al. | Regeneration in mice of injured skin, heart, and spinal cord by α-gal nanoparticles recapitulates regeneration in amphibians | |
| Ma et al. | Hydrogel for slow-release drug delivery in wound treatment | |
| Fan et al. | Biodegradable sustained-release microneedle patch loaded with clindamycin hydrochloride: a breakthrough in acne management | |
| Sun et al. | Chlorella pyrenoidosa-based antibiotic liposomal gel promotes wound healing by scavenging biofilm and accelerating regeneration | |
| Yang et al. | Construction and clinical application of a human tissue-engineered epidermal membrane | |
| JP2010502175A (ja) | Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法 |